Elsbernd Brian's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Nov 15, 2022
- Accession no.
- 0001161697-22-000549
- Filed
- Nov 15, 2022
- Trade date
- Nov 11-14, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $238.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Elsbernd BrianCIK 0001763511 | Officer (Chief Compliance/Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 11, 2022 | Common stock, par value $0.001 per share | SSaleDisposed | −14,666 | $16.24 | −$238,175.84 | 11,096 | Direct | |
| Nov 14, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +65,000 | $1.85 | +$120,250 | 76,096 | Direct | |
| Nov 14, 2022 | Common stock, par value $0.001 per share | MOption exerciseAcquired | +40,000 | $0.79 | +$31,600 | 116,096 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Stock | MOption exerciseDisposed | −65,000 | $0.00 | $0 | 885,667 | Direct | |
| Nov 14, 2022 | Common Stock | MOption exerciseDisposed | −40,000 | $0.00 | $0 | 845,667 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.